Merck CEO on upbeat guidance: ‘our COVID pill will make a meaningful difference’

Merck & Co Inc (NYSE: MRK) reported its financial results for the third quarter on Thursday that beat Wall Street estimates. Shares of the pharmaceutical company were up 2.0% in premarket trading on upbeat guidance for the full year. Highlights from CEO Davis’ interview with CNBC’s ‘Squawk Box’ On CNBC’s “Squawk Box”, CEO Robert Davis […]